Which of the following companies is likely to incur higher cost of financial distress in an economic downturn? Justify your answer. Company A: A one-year old bio-tech company. So far, none of the companys product has been approved for sale, but its scientists are working very hard in developing a breakthrough drug. Company B: An oil and gas company. The company has 50 producing wells and 20 million barrels of proven oil reserves.